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Mutations in the short stature homeobox gene SHOX lead to growth retardation associated with Turner, Leri-Weill dyschondrosteosis, and
Langer mesomelic dysplasia syndromes, which marked the shortening of the forearms and lower legs. We report here that in contrast to the SHOX
mutations in humans, Shox2 deficiency in mice leads to a virtual elimination of the stylopod in the developing limbs, while the zeugopod and
autopod appear relatively normal. This phenotype is consistent with the restriction of the Shox2 expression to the proximal mesenchyme in the
limb bud and later to chondrocytes associated with the forming stylopod. In the Shox2−/− embryo, the mesenchymal condensation for the stylopod
initiates normally but the cartilaginous element subsequently fails in growth, chondrogenesis and endochondral ossification. A dramatic down-
regulation of Runx2 and Runx3 could account for the lack of chondrocyte hypertrophy, while a down-regulation of Ihh expression may be
responsible for a significant reduction in chondrocyte proliferation in the mutant stylopod. We further demonstrate that an enhanced and ectopic
Bmp4 expression in the proximal limb of the Shox2 embryo may underlie the down-regulation of Runx2, as ectopically applied exogenous BMP4
represses Runx2 expression in the early limb bud. Moreover, we show that mouse Shox2, similar to human SHOX, can perform opposite roles on
gene expression: either as a transcription activator or a repressor in different cell types. Our results establish a key role for Shox2 in regulating the
growth of stylopod by controlling chondrocyte maturation via Runx2 and Runx3.
© 2007 Elsevier Inc. All rights reserved.Keywords: Shox2; Runx2; BMP4; Mouse; Limb patterning; ChondrogenesisIntroduction
The vertebrate limb contains three distinct compartments
along the proximodistal (PD) axis, the stylopod, zeugopod, and
autopod, which are defined by the number, size, shape and the
arrangement of skeletal elements. Limb grows and lengthens in
a PD sequence, either with skeletal elements specified
progressively, as hypothesized in the progress zone model
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doi:10.1016/j.ydbio.2007.03.518differentiation of elements that were specified in the early limb
bud, as proposed in the early specification model (Dudley et al.,
2002). Regardless of the mechanism for early specification,
subsequent growth of each element is essential for achieving the
eventual pattern of the limb skeleton, but the molecular
mechanisms for this later phase of development have only
begun to be elucidated. Most notably, members of the fibroblast
growth factors (FGFs) expressed in the apical ectodermal ridge
(AER), including FGF4, FGF8, FGF9 and FGF17, collectively
are essential for the outgrowth of the limb bud (Fallon et al.,
1994; Niswander et al., 1994; Niswander, 2003). In particular,
removal of Fgf8 in the AER of developing mouse limbs causes
a severe reduction in the stylopod (Lewandowski et al., 2000;
Moon and Capecchi, 2000). In addition, the Hox genes,
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eventual pattern of the limb skeleton, as deletions of Hoxa10,
Hoxc10 and Hoxd10 drastically shorten the femur, whereas
loss of Hoxa11 and Hoxd11 results in a virtual loss of the radius
and the ulna (Davis et al., 1995; Wellik and Capecchi, 2003;
Boulet and Capecchi, 2004). Finally, two closely related
homeobox genes Meis1 and Meis2, which encode Hox
cofactors, exhibit a restricted expression pattern in the proximal
limb region and are thought to be the determinants of proximal
limb compartments (Capdevila et al., 1999; Mercader et al.,
1999, Moens and Selleri, 2006). Ectopic expression of either
Meis1 or Meis2 in developing chick limbs reduces or truncates
distal limb compartments (Capdevila et al., 1999; Mercader et
al., 1999). However, targeted disruption of Meis1 in mice does
not result in an obvious PD defect in limbs (Hisa et al., 2004).
The vertebrate limb skeleton is derived from cartilage
templates that form from mesenchymal condensations, and are
eventually replaced by bone. Whereas growth factors such as
BMPs and TGF-βs, Hox and Pax homeodomain transcription
factors, and cell adhesion and ECM molecules have all been
implicated in mesenchymal condensation and subsequent
differentiation of chondrocytes (Hall and Miyake, 2000), the
HMG transcription factor Sox9 is essential for cartilage
formation (Akiyama et al., 2002). Upon formation of the
cartilage primordium, chondrocytes initially all proliferate but
subsequently those residing at the middle of the element exit the
cell cycle and undergo hypertrophy. Proper proliferation of
chondrocytes requires Indian hedgehog (Ihh), as mouse
embryos lacking Ihh exhibit a profound defect in proliferation
(St-Jacques et al., 1999; Long et al., 2001). In addition, the
transition from proliferation to hypertrophy is negatively
regulated by IHH, which induces PthrP in chondrocytes and
perichondrial cells within the periarticular region; PTHrP in turn
keeps chondrocytes in the proliferating pool and prevents
premature entry to hypertrophy (Lanske et al., 1996; Vortkamp
et al., 1996; Chung et al., 1998, Karp et al., 2000). Moreover,
Runx2, a Runt-domain transcription factor indispensable for
osteoblast differentiation (Ducy et al., 1997; Komori et al.,
1997; Otto et al., 1997), is important for chondrocyte
hypertrophy, as its removal significantly delays hypertrophy
in the stylopod although not other skeletal elements (Inada et al.,
1999; Kim et al., 1999). Importantly, Runx2-Runx3 double
knockout mice lack chondrocyte hypertrophy in all long bones,
underscoring the importance of Runx proteins in chondrocyte
maturation (Yoshida et al., 2004). Finally, Runx2 on the one
hand regulates Ihh expression in chondrocytes (Yoshida et al.,
2004), and on the other hand is regulated positively by BMP
and negatively by PTHrP (Lee et al., 2000; Gu et al., 2004; Li et
al., 2004; Friedman et al., 2006; Guo et al., 2006).
The short stature homeobox (SHOX) gene is associated with
idiopathic growth retardation, Turner syndrome, and Lëri-Weill
dyschondrosteosis in humans (Ellison et al., 1997; Rao et al.,
1997; Belin et al., 1998; Shears et al., 1998). Loss-of-function
mutations in one allele of SHOX result in a phenotype of short
stature with shortening of the forearms and lower legs, while
homozygous mutations in SHOX cause Langer mesomelic
dysplasia syndrome, a severe dwarfism with marked shorteningof the limbs and almost complete elimination of the zeugopod
(Zinn et al., 2002). SHOX2, a second member of the SHOX
family, has an overall 83% homology at the amino acid level
and an identical homeodomain as SHOX (Blaschke et al., 1998;
Semina et al., 1998). In the developing limbs of human
embryos, SHOX and SHOX2 exhibit a partially overlapping but
complementary expression pattern, with SHOX expressed in a
domain that is more distal relative to SHOX2. The distal SHOX
expression domain is coincident with the skeletal defects
observed in patients with Leri-Weill dyschondrosteosis and
Langer mesomelic dysplasia (Clement-Jones et al., 2000). A
zooblot analysis of SHOX and SHOX2 demonstrates that they
are only present in all vertebrates studies but not in the
invertebrates examined, suggesting that these two genes have a
central role in the development of the internal skeleton and its
related structures (Clement-Jones et al., 2000). The mouse
SHOX ortholog does not exist, but a true Shox2 ortholog does,
which shares 99% identity at the amino acid level with its
human counterpart (Rovescalli et al., 1996; Blaschke et al.,
1998; Semina et al., 1998; Clement-Jones et al., 2000). Since
SHOX2 has not yet been linked to any known syndromes in
humans so far, its role in skeletogenesis, particularly in limb
development, remains unknown.
We have previously generated Shox2 mutant mice via gene
targeting (Yu et al., 2005). Here we report detailed analyses of
the Shox2mutant limb phenotype at the morphological, cellular,
and molecular levels.Materials and methods
Mice and embryos
Shox2 mutant mice were generated via gene targeting and have been
maintained on C57BL/6 background, as reported previously (Yu et al., 2005).
Mice and embryos were genotyped by a PCR-based method using genomic
DNA extracted from tail or extra-embryonic membranes, as described
previously (Yu et al., 2005). Embryonic age was determined by the day when
the vagina plug was discovered and designated as embryonic day 0.5 (E0.5).
Skeletal preparation, histology, and BrdU labeling
Skeletal staining was performed using Alcian blue for non-mineralized
cartilage and Alizarin Red for bone as described previously (Zhang et al.,
2000b). For histological analysis, tissues were fixed in 4% paraformaldehyde
(PFA) in PBS. Standard paraffin sectioning at 10 μm and hematoxylin and eosin
staining were carried out. For in vivo BrdU labeling, timed pregnant Shox2+/−
female mice (crossed with Shox2+/− male) were injected intraperitoneally with
BrdU labeling reagent (3 mg/100 g body weight). Embryos were harvested 2 h
after injection and processed for fixation, embedding, sectioning, and
immunodetection stained using a BrdU labeling and detection kit (Boehringer
Mannheim), as described previously (Zhang et al., 2002).
In situ hybridization
Section in situ hybridization was performed to examine gene expression, as
describe previously (Zhang et al., 1999). Samples were fixed in 4% PFA,
paraffin embedded, and sectioned at 10 μm. Non-radioactive riboprobes were
generated by in vitro transcription labeling with digoxigenin–UTP according to
the manufacturer’s instructions (Boehringer Mannheim). The following cDNA
fragments were used to generate antisense riboprobes: Bmp4 (1.0 kb), Col II
(500 bp), Col X (650 bp), Fgf8 (800 bp), Hoxa10 (1.3 kb), Hoxc10 (579 bp),
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Runx2 (550 bp), Runx3 (456 bp), Shox2 (550 bp), Sox9 (586 bp).
Bead implantation and organ culture
Limb buds from E11.5 wild-type embryos were microdissected in PBS and
placed on filter in the Trowell type organ culture. Affi-Gel blue agarose beads
(100–200 mesh, 75–150 μm in diameter, from Bio-Rad) that were soaked with
BMP4 protein (from R&D Systems) at a concentration of 100 ng/μl or BSA
(1 mg ml) were implanted into the proximal region of the explanted limb buds.
Samples were cultured in α-MEM media containing 10% knockout serum
replacement, 3500 mg/l glucose, 0.55 mM glycine, 0.056 mM ascorbic acid for
24 h prior to harvest for section in situ hybridization.
In vitro transfection and CAT assay
To generate constructs expressing fusion proteins with the GAL4 DNA-
binding domain, the following DNA fragments were subcloned, respectively,
into the pBXG1 vector that harbors the GAL4 DNA-binding domain under the
control of SV40 enhancer/promoter (Lillie and Green, 1989): DNA fragments
encoding the N-terminus (amino acids 1–140) and the C-terminus (amino acids
201–331) of the mouse Shox2a, the C-terminus (amino acids 71–190) of the
mouse Shox2b, the N-terminus (amino acids 1–117) and the C-terminus (amino
acids 178–292) of the human SHOXa (Blaschke et al., 1998). To test potential
transactivating activities, the resultant expression vectors were co-transfected,
respectively, with the pG5ECAT reporter plasmid containing five GAL4-binding
sites upstream of the adenovirus E1b minimal promoter and the chloramphenicol
acetyltransferase (CAT) reporter gene. To determine potential repressive
activities, the resultant expression vectors were co-transfected with the
pG5tkCAT reporter vector in which the CAT reporter gene is directed by the
herpe simplex virus thymidine kinase (TK) promoter with five GAL4-binding
sites upstream of the TATA-box. A CMV-β-gal plasmid was included in
transfection as internal control for transfection efficiency. P19 cell line and theFig. 1. Expression of Shox2 in the developing mouse limb. (A, B) Shox2 transcripts ar
limb mesenchyme at E10.5 (B). (C, D) Shox2 expression is seen in the mesenchyme
E12.5 (D). (E, F) Shox2 expression is detected in the immature chondrocytes (prolife
at E13.5 (E) and E14.5 (F). The expression in the surrounding connective tissues r
hypertrophic chondrocytes; CPC, columnar proliferating chondrocytes; PPC, periarthuman osteosarcoma cell line U20s were used for transfection and reporter gene
expression assays. Transfection and CAT assays were performed as previously
described (Yu et al., 2001; Wang et al., 2004). Transfected cells were cultured for
36 h and the CAT activities were determined by scintillation counting. Each
experiment was repeated three times to ensure consistent results.Results
Shox2 expression is restricted to the proximal region of the
developing limb
In order to reveal the expression pattern and course of Shox2
in developing mouse limb, we carried out in situ hybridization
on limbs at different developing stages. At E9.5 when the
mouse limb development initiates, Shox2 expression was found
in the limb bud mesenchyme with stronger expression in the
dorsal region (Fig. 1A). At E10.5 as limb bud elongates, Shox2
expression was confined to the mesenchyme of the proximal
limb, with stronger expression remaining in the dorsal region
(Fig. 1B). At E11.5, Shox2 transcripts were detected strongly in
the proximal limb mesenchyme associated with the stylopodial
cartilaginous condensation and relatively weakly in the
mesenchymal tissue surrounding the condensations of the
future zeugopodial skeletons (Fig. 1C). The dorsal–ventral
asymmetrical expression pattern of Shox2 was not seen at this
stage. The expression pattern remained basically the same as
that seen at E12.5 (Fig. 1D). However, at this stage
chondrocytes in both ends of the stylopod appear to exhibite detected in the limb mesenchyme at E9.5 (A) and are restricted to the proximal
of the proximal limbs surrounding the cartilaginous elements at E11.5 (C) and at
rating chondrocytes) and the perichondrium (arrows) of the stylopodial elements
emains but is down-regulated. All sections are longitudinal. H, humerus; HC,
icular proliferating chondrocytes.
Fig. 2. Chondrodysplasia of the stylopodial elements in Shox2−/− mice. (A–D)
Skeletal preparations of the wild-type and Shox2−/− forelimbs at E13.5 (A), 15.5
(B), and E17.5 (C, D) exhibit remarkable shortening of the humerus of Shox2
mutants. The distal elements of both wild-type and mutant embryonic limbs
appear comparable at the stages examined. (E, F) Longitudinal histology section
through the stylopod from E16.5 Shox2 mutant forelimb (F) shows a complete
absence of chondrocyte maturation and ossification in the humerus, as compared
to the wild-type control (E). Arrows point to the humerus. H, humerus.
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tiated hypertrophic chondrocytes have appeared in the central
portion, Shox2 expression was restricted in the proliferating
chondrocytes in the stylopodial element (Figs. 1E, F). Mean-
while, Shox2 expression remained in the connective tissues
surrounding the cartilaginous element, but appeared down-
regulated. Strong Shox2 expression was also detected in the
perichondrium (Figs. 1E, F). The unique expression pattern of
Shox2 in the developing limb suggests a role for Shox2 in the
formation of the proximal limb skeleton. Since Shox2
expression and the knockout phenotypes (described below)
are identical in both forelimb and hindlimb, to make it
consistent, we are reporting results only from the forelimb.
Shox2 deficiency leads to chondrodysplasia of the stylopod
We have previously reported the generation of Shox2 null
mutant mice that exhibit a unique cleft palate phenotype (Yu
et al., 2005). Shox2 mutants also exhibit shortened limb
reminiscent of the short stature syndrome in humans. Skeletal
preparations of the mutants revealed a marked reduction in
size of the stylopod, that was first noticeable at E12.5 (data
not shown) and became prominent by E13.5 (Fig. 2A).
Subsequently, the mutant stylopod exhibited very little
growth and failed to undergo endochondral ossification
(Fig. 2B), so that at E17.5, the latest viable stage for the
mutants (Yu et al., 2005), the mutant stylopodial skeletal
elements remained extremely undergrown and completely
unossified (Fig. 2C). The zeugopod elements of the mutant
limbs appeared normal at E13.5 (Fig. 2A), although they too
were slightly shortened, and delayed in ossification at E15.5
(Fig. 2B). At E17.5, the bone collars of the mutant zeugopod
appeared slightly shorter than normal but otherwise similar to
their wild-type counterparts (Fig. 2D). Histological examina-
tion revealed a severe defect in chondrocyte maturation in the
mutant stylopod (Fig. 2F), as no hypertrophy occurred at
E16.5, a stage when hypertrophy and ossification are
normally well underway (Fig. 2E). Thus, failure in
chondrocyte maturation underlies the dysplasia phenotype in
the stylopod of Shox2 mutants.
Failure of chondrocyte differentiation in the Shox2 mutant
stylopod
To confirm the defect in chondrocyte maturation in the
Shox2−/− stylopod, we examined by in situ hybridization the
expression of Sox9 and collagen type II (Col II), both markers
for immatured chondrocytes, and collagen type X (Col X), a
marker for hypertrophic chondrocytes. At E11.5, Sox9 expres-
sion in all skeletal anlagen including the stylopod is similar
between wild-type and Shox2−/− limbs (Figs. 3A, B), indicating
normal initiation of chondrogenesis in the Shox2−/− stylopod.
However, all chondrocytes of the Shox2−/− stylopod remained
immature at E14.5, as evidenced by the persistent expression of
Sox9 and Col II (Figs. 3D, F), and the absence of Col X
expression (Fig. 3H). In contrast, in the wild-type littermate,
Sox9 and Col II were now restricted to chondrocytes at bothends but absent in the central portion where Col X-expressing
hypertrophic chondrocytes resided (Figs. 3C, E, G). This
modification of Sox9, Col II and Col X expression is spatially
restricted to the stylopodial region since gene expression
appears similar to wild-type controls in the forming zeugopodial
skeletal elements. We conclude that the deletion of Shox2 leads
to a complete absence of chondrocyte hypertrophy in the
embryonic stylopod.
Expression of PD early patterning genes is not altered in Shox2
mutant limbs
Since Shox2 exhibits a unique restricted expression pattern
in the proximal region of the developing limb, and loss of Shox2
leads to a virtual absence of the stylopod, it is possible that
Shox2 controls early PD patterning. We therefore analyzed the
expression of a number of genes known to participate in early
PD patterning of the limb, including Hoxa10, Hoxc10,
Fig. 4. Altered Ihh expression and cell proliferation in the cartilaginous elements
of the Shox2−/− stylopod. (A, B) Ihh expression remains the same in the
mesenchymal condensations of the wild-type (A) and Shox2−/− (B) forelimbs at
E11.5. (C, D) At E12.5, Ihh expression is significantly down-regulated in the
Shox2−/− humerus (D), as compared to that in the wild-type control (C). Note the
expression of Ihh is unaltered in the elements of mutant zeugopod. (E, F) Cell
proliferation as labeled by BrdU is significantly reduced in the cartilaginous
element of Shox2−/− humerus (F), as compared to the wild-type control at E12.5
(E). Arrows point to the humerus. H, humerus; R. radius; U, ulna.
Fig. 3. Failure of chondrocyte maturation in the Shox2−/− stylopod. (A, B) Sox9
expression, which marks the precartilaginous condensations, is unaltered in the
E11.5 Shox2−/− forelimb (B), as compared to the wild-type control (A). (C, D)
Sox9 expression is restricted to the proliferating chondrocytes in the both ends of
the humerus of E14.5 wild-type embryo (C), and persists in the entire humerus
element of E14.5 Shox2mutant (D). (E, F) At E14.5, Col II expression begins to
recess from the middle sector of the wild-type humerus (E), but remains in the
entire Shox2−/− humerus (F). (G) Col X expression in the E14.5 wild-type
humerus indicates the presence of hypertrophic chondrocytes. (H) An E14.5
Shox2−/− forelimb shows the lack of Col X expression in the humerus. Arrows
point to the humerus. H, humerus; R, radius; U, ulna.
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of these genes altered its expression pattern in the mutant limb
bud (Supplementary Figs. 1, and 2). Thus, the assayed genes do
not appear to be downstream targets of Shox2, but may function
upstream of or in parallel to Shox2 in normal limb development.Shox2 controls the expression of Ihh, Runx2 and Runx3 in the
stylopodial
Since chondrocytes of the Shox2−/− stylopod failed to
undergo hypertrophy, we examined the expression of several
genes known to play crucial roles in chondrocyte maturation,
including Ihh, Pthrp, Runx2, and Runx3. In the normal limb,
Ihh expression initially appears in the chondrogenic mesench-
ymal condensations at E11.5 (Fig. 4A), and then in nascent
cartilage at E12.5 (Fig. 4C). Subsequently Ihh expression is
restricted to the prehypertrophic chondrocytes of developing
long bones (Bitgood and McMahon, 1995; St-Jacques et al.,
554 L. Yu et al. / Developmental Biology 306 (2007) 549–5591999; and data not shown). In the Shox2−/− limbs, at E11.5 Ihh
was expressed in a wild-type pattern in all skeletal condensa-
tions including the presumptive stylopodial element (Fig. 4B).
However, by E12.5 Ihh expression was almost completely lost
in the Shox2−/− stylopod (Fig. 4). Interestingly, Ihh expression
in the mutant zeugopod remained normal, suggesting a specific
role of Shox2 in maintaining Ihh expression in the stylopod.
Consistent with the drastic down-regulation of Ihh expression,
and the known proliferative role of Ihh (St-Jacques et al., 1999;
Long et al., 2001), chondrocyte proliferation in the Shox2−/−
stylopod was significantly reduced at E12.5 (Figs. 4E, F). Thus,
the failure to maintain Ihh in the Shox2−/− stylopod may
account for the decrease in chondrocyte proliferation, and in
part the reduction in stylopod growth.Fig. 5. Down-regulation of Runx2 and Runx3 in the cartilaginous elements of the Sho
exhibit an identical expression pattern restricted to the mesenchymal condensation
expression is dramatically down-regulated in the condensation of the humerus, but re
Runx3 expression continues in the cartilaginous elements of the wild-type limbs (E, G
the expression of Runx genes remains in the cartilaginous elements of the Shox2−/− z
perichondrium and hypertrophic chondrocytes of the wild-type humerus (I, K), but is
H, humerus; R, radius; U, ulna.We next examined expression of PTHrP, known to critically
regulate chondrocyte hypertrophy. Interestingly, at E12.5 when
Ihh is down-regulated in the Shox2−/− stylopod, Pthrp
expression appeared normal in this element (supplementary
Fig. 3), suggesting that the residual Ihh in the mutant stylopod is
sufficient to maintain PthrP expression.
Finally, we examined the expression of Runx2 and Runx3 in
the developing stylopod of Shox2−/− versus wild-type littermate
embryos. In wild-type embryos, Runx2 and Runx3 are detected
in the central portions of chondrogenic condensations at E11.5
(Figs. 5A, C), and of nascent cartilage at E12.5 (Figs. 5E, G).
From E13.5 onward, Runx2 and Runx3 are more restricted in
pre- and early hypertrophic chondrocytes, in addition to their
expression in the perichondrium (Figs. 5I, K, and data notx2−/− stylopod. (A–D) In E11.5 wild-type forelimbs, Runx2 (A) and Runx3 (C)
s. In limbs from Shox2 mutant of the same stage, Runx2 (B) and Runx3 (D)
mains similar in the condensations of the zeugopod. (E–H) At E12.5, Runx2 and
), but is almost completely absent in the humerus of Shox2 mutant (F, H). Note
eugopod. (I–L) At E13.5 the expression of Runx2 and Runx3 is detected in the
completely absent in the Shox2−/− humerus (J, K). Arrows point to the humerus.
Fig. 6. Up-regulated BMP4 represses Runx2 expression in the early limbs. (A)
Bmp4 expression is detected in the mesenchymal condensations of an E11.5
wild-type forelimb. (B) Ectopic expression of Bmp4 is detected in the
mesenchymal tissues (arrows) surrounding the humerus condensation of
E11.5 Shox2−/− forelimb. (C) At E12.5, Bmp4 expression is seen in the
perichondral region, with higher level at the both ends of the humerus of the
wild-type forelimb. (D) Ectopically expressed Bmp4 is detected in the
mesenchymal tissues (arrows) surrounding the humerus of an E12.5 Shox2
mutant. Arrowheads point to the strong expression of Bmp4 in the perichondrial
region. (E, F) An E11.5 wild-type forelimb, after 24 h in culture with an
implanted BMP4-soaked bead, shows completely abolished Runx2 expression
in the humerus element (arrow) (F), as compared to control which received a
BSA-soaked bead (E). H, humerus; R, radius; U, ulna.
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were either dramatically down-regulated (Fig. 5B) or
undetectable (Fig. 5C) in the presumptive stylopod at E11.5.
Runx2 expression was further reduced at E12.5 (Fig. 5F)
and became undetectable by E13.5 (Fig. 5J), whereas Runx3
remained undetectable in the stylopod at all stages examined
(Figs. 5H, L). Thus the loss of Runx2 and Runx3 expression at
early stages of cartilage development may be responsible for the
failure of chondrocyte maturation in the Shox2−/− stylopod.
Regulation of Runx2 expression by Shox2 is mediated by BMP4
Since Shox2 expression in the E11.5 and E12.5 proximal
limb mesenchyme normally exhibits a complementary, rather
than overlapping pattern to the stylopodial condensation that
expression Runx2 and Runx3 (Figs. 1 and 5), it appears
unlikely that Runx2 and Runx3 are direct targets of Shox2.
Instead, we hypothesized that a diffusible factor(s) regulated by
Shox2 in the surrounding limb mesenchyme may regulate Runx
genes in the cartilage. In an expression survey by in situ
hybridization, Bmp4 was identified as such a candidate. In the
proximal region of a wild-type limb primordium, Bmp4 was
initially expressed in the condensations of stylopod and
zeugopod at E11.5 (Fig. 6A), but became restricted to the
perichondrium and the surrounding mesenchyme, with the
highest level at the ends of the stylopod by E12.5 (Fig. 6C).
Strikingly, in Shox2−/− limbs, Bmp4 expression was broadly
activated in the mesenchyme surrounding the stylopod at E11.5
(Fig. 6B), and markedly up-regulated in both the perichondrium
and the surrounding mesenchyme at E12.5 (Fig. 6D). These
observations raised the possibility that elevated Bmp4 expres-
sion may be responsible for the repression of Runx2 and Runx3
in the mutant stylopod.
To examine the potential for BMP4 to regulate Runx2
expression, we performed bead implantation experiments on
limb buds in vitro. As shown in Fig. 6, Runx2 expression was
detected in both chondrocytes and the perichondrium of the
control humerus implanted with BSA control bead (Fig. 6E;
5/5), but was completely inhibited in the samples treated with
BMP4 (Fig. 6F; 10/10). Our previous studies have clearly
shown that similar application of exogenous BMP4 to the
mouse developing limb buds at the same concentration
(100 ng/μl) does not enhance cell death in the limb bud
mesenchyme (Zhang et al., 2000a). These results demonstrate
that high levels of BMP4 can inhibit Runx2 expression. It is
therefore possible that BMP4 up-regulation in the Shox2−/−
limb underlies the down-regulation of Runx2.
Shox2 protein can act as either a transcriptional repressor or
an activator
Previous studies have demonstrated that the human SHOX
protein functions as a potential transcription activator, with its
transactivation domain residing within the C-terminus (Rao et
al., 2001). To determine if the mouse Shox2 gene encodes a
transcription activator or a repressor and to map the functional
domain within the protein, we carried out in vitro reportergene assays. The mouse Shox2 gene encodes two isoforms
Shox2a and Shox2b (Blaschke et al., 1998). The Shox2b
isoform has an extremely short N-terminal amino acid sequence
with only 6-amino-acid residues prior to the homeodomain and
a C-terminus missing a sequence of 12-amino-acid residues
present in the Shox2a isoform. We thus tested the transcriptional
activities of the N- and C- terminal domains from Shox2a and
the C-terminus of Shox2b. We generated constructs in which the
N-terminus (the first amino acid to the amino acid prior to the
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amino acid immediately after the homeodomain to the last
amino acid) of Shox2a and Shox2b were fused in frame to the
147-amino-acid DNA-binding domain of yeast GAL4. The N-
and C-termini of the human SHOXa were used as controls.
These constructs were co-transfected, respectively, with the
pG5ECAT reporter plasmid to determine transactivation activ-
ity, and with the pG5tkCAT reporter vector for transcriptional
repressive activity, as previously reported (Yu et al., 2001;
Wang et al., 2004). The results demonstrate that the transcrip-
tion activity of Shox2 protein resides within the C-terminus of
either isoforms, with no significant activity detected in the N-
terminus of Shox2a (Fig. 7). Interestingly, the C-terminal
sequences acted as a transcriptional activator in the osteogenic
cell line U20s (17-fold for Shox2a, 14-fold for Shox2b), but as a
repressor in P19 cells (about 4-fold repression for both C-
termini) (Fig. 7). Similarly, we found that the C-terminus of
human SHOXa also activated in U20s cells but repressed
transcription in P19 cells (data not shown). Thus, both mouse
Shox2 and human SHOX can either activate or repress
transcription in different cell types.
Discussion
Mice lacking Shox2 die prenatally and exhibit severe
abnormalities in several developing organs (Yu et al., 2005).
Here we report a unique limb phenotype in the mutant mice:
limbs form but develop chondrodysplasia specifically in the
stylopod, resulting in the virtual absence of the humerus andFig. 7. Mapping of transcriptional regulatory domain of Shox2. In U20s cells,
co-transfection of the pG5ECAT reporter plasmid with the indicated constructs
demonstrates that the C-termini of Shox2a and Shox2b have strong
transactivating potential, while the N-terminus of Shox2a does not affect
reporter gene expression, as measured by the CAT activities. pBGX1 is used as
control. In contrast, the C-termini of both Shox2a and Shox2b but not the
N-terminus, after co-transfection with the pG5tkCAT reporter plasmid, repress
reporter gene expression in P19 cells.femur. Our studies showed that a complete absence of
chondrocyte maturation and a marked decrease in proliferation
in the stylopod underlies the chondrodysplasia phenotype. Our
results are consistent with that reported in a recent study in
which Shox2 was conditionally removed in developing limbs
(Cobb et al., 2006). However, we have further demonstrated that
Shox2 regulates the expression of Runx genes, via control of
BMP4, to control chondrocyte maturation. Shox2 protein acts
either as a transcription activator or a repressor in different cell
types.
Shox2 is essential for patterning the proximal limbs in mice
Consistent with the restricted expression of Shox2 in the
proximal region of developing limbs, the absence of Shox2
essentially eliminates of the stylopod, while the more distal
structures, including the zeugopod and the autopod, appear
relatively normal. The defect was unlikely due to early
patterning defects, as the stylopod primordia appeared normal
at early stages, and expression of known patterning genes
including Hoxa10, Hoxc10, Hoxd10, Meis1, Meis2, and Fgf8
was not altered in Shox2 mutants (data not shown). Similarly,
expression of Hoxd9, Hoxd11, Hoxd13 and Hoxa11 was
reported normal in the limbs of Shox2 limb-specific knockout
embryos (Cobb et al., 2006). Moreover, a recent study reported
that over-expression of the chick Shox gene led to consistent
elongation of skeletal elements of chick limbs but a normal PD
patterning with unaltered expression of Hoxa13, Hoxd11, and
Meis1 (Tiecke et al., 2006).
Shox2 regulates chondrocyte maturation via controlling Runx
gene expression
Chondrocyte maturation in long bones is regulated by an
integration of multiple signaling pathways, including BMP,
FGF, Wnt, and IHH/PTHrP pathways (Akiyama et al., 2004;
Minina et al., 2001, 2002). Members of the Runx gene family,
particularly Runx2, play an essential role in chondrocyte
maturation, most likely by mediating the functions of these
signaling pathways. Our results demonstrate that Shox2
functions genetically upstream of Runx2 and Runx3 in the
stylopod, as expression of Runx2 and Runx3 was significantly
down-regulated in the Shox2 mutant. Loss of Runx2 and
Runx3 could in turn accounts for the lack of hypertrophic
chondrocytes in the Shox2−/− stylopod. The lack of hyper-
trophy in our mutant mice appears to represent an extreme
delay in maturation, as hypertrophic chondrocytes were
reported to eventually occur in the limb-specific Shox2
knockout animals (Cobb et al., 2006).
Shox2 apparently does not regulate the expression of Runx
genes directly, at least not at the early stage of limb
development. This is supported by the observations that at
E11.5, Shox2 expression does not overlap with that of Runx2
and Runx3 in the proximal limbs, even though a down-
regulation of Runx2 and Runx3 occurs in the Shox2 mutants at
this stage. We have provided evidence that BMP4 may mediate
the indirect regulation of Runx2 by Shox2. First, Bmp4
557L. Yu et al. / Developmental Biology 306 (2007) 549–559expression was markedly up-regulated both in the normal
domains as well as ectopically in the proximal limbs of Shox2
mutants. Second, exogenous BMP4 is able to repress Runx2
expression in the cartilaginous elements of wild-type limbs. It is
therefore conceivable that in the normal mouse limb develop-
ment, Shox2 functions to repress Bmp4 expression in the
proximal limbs, allowing the activation of Runx genes. In this
scenario, Shox2 may act as a transcriptional repressor. Our in
vitro reporter gene expression assays indicate that this can
indeed be the case in certain cell types. Roles of BMPs in
chondrogenesis have been previously reported (Capdevila and
Johnson, 1998; Minina et al., 2001, 2002; Pathi et al., 1999;
Pizette and Niswander, 2000; Yoon et al., 2005). However,
BMP signals were previously shown to activate Runx2
expression in micromass culture of embryonic limb mesench-
yme as well as C2C12 mouse myoblast precursor cells (Lee et
al., 2000; Gu et al., 2004; Wang et al., 2005). The seemingly
contradictory results on the regulation of Runx2 by BMP could
be explained by the differences in experimental systems and/or
levels of BMP signaling, as BMP4 was previously shown to
exert opposite roles on the regulation of Shh expression in
developing teeth (Zhang et al., 2000a). The regulation of Runx2
by BMP may not be direct, since neither BMP nor Smad
affected the activities of a mouse Runx2 promoter (Xiao et al.,
2001; Lee et al., 2002).
Contribution of Ihh down-regulation to the decrease in growth
of mutant stylopods
Previous studies have revealed a crucial role of IHH in
chondrocyte proliferation (St-Jacques et al., 1999) in part by
modulating the expression of cyclin D1 (Long et al., 2001). In
Shox2 mutants, Ihh expression initiated normally in the
developing limb at E11.5 but greatly diminished in the
stylopod by E12.5. Also at E12.5, chondrocyte proliferation
in the stylopod was significantly reduced, consistent with the
role of IHH in chondrocyte proliferation. We therefore
conclude that Ihh down-regulation is at least partially
responsible for the proliferation defect in the Shox2 mutant
stylopod. However, Shox2 is unlikely to regulate Ihh expres-
sion directly, since expression Shox2 does not overlap with that
of Ihh in the early limbs. Instead, the down-regulation of
Runx2 and Runx3 may be responsible for the loss of Ihh
expression in the Shox2 mutant stylopod, as Ihh expression
was dramatically down-regulated in the Runx2-Runx3 double
mutant limbs and Runx2 strongly induced Ihh expression by
directly binding to the promoter region of Ihh gene (Yoshida et
al., 2004).
Shox2 can function as a transcriptional repressor or activator
Members of SHOX gene family (SHOX and SHOX2) encode
the homeodomain-containing transcriptional regulators. The
human SHOX proteins were shown to act as transcriptional
activator, with its transactivation domain mapped to the C-
terminal region (Rao et al., 2001). However, the transactivating
activity of SHOX was observed only in cells of osteogenicorigin, indicating that specific co-factors are required for the
transcriptional activation function of SHOX (Rao et al.,
2001). In this study, we show that the C-terminal region of
mouse Shox2 possesses strong transactivating activities in the
osteogenic cell line U20s. To our surprise, the same domain
of Shox2 exerted an opposite effect on the expression of
reporter gene in P19 cell line. Similar dual activities were
observed with the C-terminus of human SHOX, indicating
that both SHOX and Shox2 can act as either a transcriptional
activator or a repressor, depending on the cell-type-specific
co-factors.
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